403 related articles for article (PubMed ID: 2499268)
21. [Selective enhancement of tumor blood flow and drug delivery to brain tumors in experimental rat gliomas under angiotensin II-induced hypertension].
Ogasawara H; Kiya K; Kurisu K; Hotta T; Mikami T; Sugiyama K; Uozumi T
No To Shinkei; 1991 Jul; 43(7):657-62. PubMed ID: 1910950
[TBL] [Abstract][Full Text] [Related]
22. Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy.
Adam JF; Joubert A; Biston MC; Charvet AM; Peoc'h M; Le Bas JF; Balosso J; Estève F; Elleaume H
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):603-11. PubMed ID: 16338098
[TBL] [Abstract][Full Text] [Related]
23. [Chemotherapeutic strategy in rat brain tumor cells resistant to ACNU using an in vitro colony formation assay].
Mineura K; Sasaki J; Fushimi S; Sasajima H; Ishino Y; Kowada M
No To Shinkei; 1989 Sep; 41(9):927-32. PubMed ID: 2590562
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacokinetics and antitumor activity of MX2, a new morpholino anthracycline in brain tumor intracerebral transplanted in rats].
Kiya K; Ogasawara H; Fujita H; Sugiyama K; Kurisu K; Kawamoto K; Uozumi T; Shinkai H
Gan To Kagaku Ryoho; 1993 Apr; 20(5):631-5. PubMed ID: 8470921
[TBL] [Abstract][Full Text] [Related]
25. [Possibility of overcoming ACNU resistance in ACNU-resistant sublines of rat brain tumors in vitro by a calmodulin inhibitor].
Yoshida T; Shimizu K; Mogami H; Sakamoto Y; Egawa T
No Shinkei Geka; 1987 Feb; 15(2):143-9. PubMed ID: 3470626
[TBL] [Abstract][Full Text] [Related]
26. Long-term survival in a rodent brain tumor model by bradykinin-enhanced intra-arterial delivery of a therapeutic herpes simplex virus vector.
Rainov NG; Dobberstein KU; Heidecke V; Dorant U; Chase M; Kramm CM; Chiocca EA; Breakefield XO
Cancer Gene Ther; 1998; 5(3):158-62. PubMed ID: 9622099
[TBL] [Abstract][Full Text] [Related]
27. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
[TBL] [Abstract][Full Text] [Related]
28. Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study.
Côté J; Savard M; Bovenzi V; Dubuc C; Tremblay L; Tsanaclis AM; Fortin D; Lepage M; Gobeil F
Neuropeptides; 2010 Apr; 44(2):177-85. PubMed ID: 20080302
[TBL] [Abstract][Full Text] [Related]
29. Synchrotron microbeam radiation therapy for rat brain tumor palliation-influence of the microbeam width at constant valley dose.
Serduc R; Bouchet A; Bräuer-Krisch E; Laissue JA; Spiga J; Sarun S; Bravin A; Fonta C; Renaud L; Boutonnat J; Siegbahn EA; Estève F; Le Duc G
Phys Med Biol; 2009 Nov; 54(21):6711-24. PubMed ID: 19841517
[TBL] [Abstract][Full Text] [Related]
30. [Chemotherapy for experimental subarachnoid dissemination model of brain tumor].
Yamashita T; Shinonaga M; Ishiwata Y; Nishimura S; Murai M; Kyuma Y; Kuwabara T
No Shinkei Geka; 1984 Jan; 12(1):47-53. PubMed ID: 6585681
[TBL] [Abstract][Full Text] [Related]
31. Influence of modes of ACNU administration on tissue and blood drug concentration in malignant brain tumors.
Hori T; Muraoka K; Saito Y; Sasahara K; Inagaki H; Inoue Y; Adachi S; Anno Y
J Neurosurg; 1987 Mar; 66(3):372-8. PubMed ID: 3469331
[TBL] [Abstract][Full Text] [Related]
32. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
[TBL] [Abstract][Full Text] [Related]
34. [Overcoming of ACNU resistance in an ACNU-resistant subline of rat C6 glioma in vivo through enhanced effect of ACNU by calmodulin inhibitor].
Yoshida T; Shimizu K; Hayakawa T; Mogami H; Sakamoto Y; Egawa T
No Shinkei Geka; 1987 Mar; 15(3):261-7. PubMed ID: 3474542
[TBL] [Abstract][Full Text] [Related]
35. [Application of interleukin 1 in the treatment of malignant gliomas with special reference to the experimental combination therapy with ACNU].
Tanaka S
Gan To Kagaku Ryoho; 1990 Jun; 17(6):1157-64. PubMed ID: 2350191
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of malignant gliomas by selective intraarterial infusion chemotherapy with high-dose ACNU and autologous bone marrow transplantation--preliminary report].
Nakagawa H; Murasawa A; Taki T; Nakajima S; Niiyama K; Furuta Y; Fujita T; Tsuruzono K; Nakamura H; Shibata H
Gan To Kagaku Ryoho; 1991 Nov; 18(14):2435-40. PubMed ID: 1659327
[TBL] [Abstract][Full Text] [Related]
37. [Circumvention of ACNU-resistance in rat glioma cells by pretreatment with O6-methylguanine].
Mineura K; Fushimi S; Sasaki J; Sasajima H; Ishino Y; Kowada M
Gan To Kagaku Ryoho; 1989 Feb; 16(2):259-62. PubMed ID: 2919893
[TBL] [Abstract][Full Text] [Related]
38. Radiofrequency electromagnetic fields have no effect on the in vivo proliferation of the 9L brain tumor.
Higashikubo R; Culbreth VO; Spitz DR; LaRegina MC; Pickard WF; Straube WL; Moros EG; Roti JL
Radiat Res; 1999 Dec; 152(6):665-71. PubMed ID: 10581537
[TBL] [Abstract][Full Text] [Related]
39. Increase in brain tumor permeability in glioma-bearing rats with nitric oxide donors.
Yin D; Wang X; Konda BM; Ong JM; Hu J; Sacapano MR; Ko MK; Espinoza AJ; Irvin DK; Shu Y; Black KL
Clin Cancer Res; 2008 Jun; 14(12):4002-9. PubMed ID: 18559623
[TBL] [Abstract][Full Text] [Related]
40. Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting.
Brigger I; Morizet J; Aubert G; Chacun H; Terrier-Lacombe MJ; Couvreur P; Vassal G
J Pharmacol Exp Ther; 2002 Dec; 303(3):928-36. PubMed ID: 12438511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
